ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676345 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676345; 2) Community: the network communities that were significantly associated with the response to NSC 676345; 3) Molecule: the relationships between components within communities and NSC 676345; 4) MDR: the compounds that were significantly associated with the NSC 676345.

NSC Compound Enrichment Correlation
NSC 132313 Dianhydrogalactitol 0.022188614181866 0.29395301
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.022188614181866 0.32463735
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.022188614181866 0.088093804
NSC 335995 Null 0.022188614181866 0.034533337
NSC 603071 Aminocamptothecin 0.022188614181866 0.21121161
NSC 606497 Camptothecin Derivative 0.022188614181866 0.19304887
NSC 617394 Null 0.022188614181866 0.34012462
NSC 633514 Null 0.022188614181866 0.14201329
NSC 643846 Null 0.022188614181866 0.00051001192
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.022188614181866 0.17565761
Total:51  Current:24    [First] [Prev] [Next] [Last]